Results 281 to 290 of about 3,107,227 (309)

Cardio‐oncology care in the era of the coronavirus disease 2019 (COVID‐19) pandemic: An International Cardio‐Oncology Society (ICOS) statement

Ca-A Cancer Journal for Clinicians, 2020
Daniel J Lenihan, Joseph Carver, Charles Porter   +2 more
exaly  

Intrathecal 2-hydroxypropyl-β-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1–2 trial

Lancet, The, 2017
Xuntian Jiang, Elizabeth M Berry-Kravis, Cristin D Davidson   +2 more
exaly  

Antiangiogenic therapy: impact on invasion, disease progression, and metastasis

Nature Reviews Clinical Oncology, 2011
John M Ebos
exaly  

Progress in Arterial Disease

Scottish Medical Journal, 1964
J, ALLAN, W, BURNETT, F D, LEE
openaire   +2 more sources

Disease progression in Parkinson’s disease

Journal of the Neurological Sciences, 2017
Y. Morita, Y. Osaki, T. Furushima, Y. Miyamoto, K. Furuta, H. Furuya   +5 more
openaire   +1 more source

Strategies to improve monitoring disease progression, assessing cardiovascular risk, and defining prognostic biomarkers in chronic kidney disease

Kidney International Supplements, 2017
Peter Stenvinkel, Matthias Kretzler, Dwomoa Adu   +2 more
exaly  

Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy

Lancet, The, 2004
Vincent C Emery, Paul D Griffiths, Caroline A Sabin   +2 more
exaly  

Disease Progression

2013
openaire   +1 more source

Imaging of onset and progression of Alzheimer's disease with voxel-compression mapping of serial magnetic resonance images

Lancet, The, 2001
William R Crum, Jonathan M Schott, Martin N Rossor   +2 more
exaly  

THE PROGRESSION OF LUNG CANCER

Ca-A Cancer Journal for Clinicians, 1951
exaly